Earnings Call · Q2 FY2023·2023-08-09

Q2 23EPS 0.00%·Rev n/aQ1 23EPS +25.00%·Rev n/aQ4 22EPS 0.00%·Rev n/aQ3 22EPS -14.29%·Rev n/a⚠ consensus missing

ADMA BIOLOGICS, INC. ADMA

Skyler Bloom — Unknown (likely Investor Relations or Corporate Communications)

Adam Grossman — President and Chief Executive Officer

Brian Lenz — Executive Vice President, Chief Financial Officer

+6.2%1d on move date+6.1% vs SPY3d+13.5%5d+9.4%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ADMA calls or request research access.

More ADMA calls Browse calls Request research access